2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Thursday, June 8, 2017

1:15pm-2:45pm: Increased hippocampal activation in Parkinson’s disease related amnestic mild cognitive impairment

K. Perepezko, A. Gold, A. Bakker, G. Pontone, C. Speck, L. Rosenthal (Baltimore, MD, USA)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Injection guidance use in the management of cervical dystonia with botulinum toxin

D. Charles, T.M. Chung, C. Colosimo, V. Misra, P. Maisonobe, S. Om (Nashville, TN, USA)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Innovative recruitment strategies accelerate enrollment of genetic mutation carriers in the Parkinson’s Progression Markers Initiative (PPMI)

V. Arnedo, S. Lasch, T. Foroud, L. Heathers, J. Martorelli, C. Halter, N. Ryerson, J. Verbrugge, L. Cook, K. Marek (New York, NY, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Inpatient care for stiff person syndrome in the United States: A nationwide readmission study

J. Crispo, D. Thibault, Y. Fortin, A. Willis (Sudbury, ON, Canada)

Other · Exhibit Hall C

1:15pm-2:45pm: Intensive Short-Term Dance Intervention in Parkinson’s Disease

D. Rabinovich, J. DeSouza, T. Arakaki, S. Rodriguez Quiroga, V. Litvak, J. Firmani, N. Garreto (Toronto, ON, Canada)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C

1:15pm-2:45pm: Interactions between amyloid-β and microglial activation in Parkinson’s disease

C. Ghadery, Y. Koshimori, J. Kim, S. Coakeley, M. Harris, L. Christopher, P. Rusjan, A. Lang, S. Houle, A. Strafella (Toronto, ON, Canada)

Parkinson's Disease: Neuroimaging And Neurophysiology · Exhibit Hall C

1:15pm-2:45pm: Interim Results of an Ongoing Open-label Safety Study of ADS-5102 (amantadine hydrochloride) Extended-Release Capsules for Treatment of Levodopa-Induced Dyskinesia (LID) (EASE LID 2 Study)

R. Hauser, R. Pahwa, C. Tanner, W. Oertel, S. Isaacson, M.J. Stempien, L. Felt, R. Johnson (Tampa, FL, USA)

Clinical Trials and Therapy in Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Intermuscular and cortico-muscular coherence of patients with writer’s cramp

H. Kumar, S. Choudhury, P. Chatterjee, R. Singh, S. Trivedi, S. Shubham, M. Baker, S. Baker (Kolkata, India)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: Intracranial calcifications and dystonia associated with a novel deletion encompassing SLC20A2 and THAP1

L. Tochen, H. Singer, K. Baranano (Washington, DC, USA)

Dystonia · Exhibit Hall C

1:15pm-2:45pm: INTREPID Trial: A Prospective, Double blinded, Multi-center Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple-Source, Constant-Current Rechargeable System in Parkinson’s Disease

J. Vitek, R. Jain, P. Starr (Minneapolis, MN, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment · Exhibit Hall C